CLINICAL RESEARCH: CARDIAC FINDINGS IN CUSHING'S SYNDROME
Left ventricular structural and functional characteristics in Cushings syndrome
Maria Lorenza Muiesan, MD*,*,
Mario Lupia, MD ,
Massimo Salvetti, MD*,
Consuelo Grigoletto, MD ,
Nicoletta Sonino, MD ,
Marco Boscaro, MD ,
Enrico Agabiti Rosei, MD*,
Franco Mantero, MD and
Francesco Fallo, MD¶
* Department of Medical and Surgical Sciences, Internal Medicine, University of Brescia, Brescia, Italy
Cardiology, Padova, Italy
Endocrinology, Padova, Italy
Medical Therapeutics Divisions, University of Padova, Padova, Italy
¶ Endocrinology Division, University of Ancona, Ancona, Italy
Manuscript received November 26, 2002;
revised manuscript received March 3, 2003,
accepted March 20, 2003.
* Reprint requests and correspondence: Prof. Maria Lorenza Muiesan, Department of Medical and Surgical Sciences, University of Brescia, c/o 2a Medicina, Spedali Civili, 25100, Brescia, Italy. muiesan{at}med.cci.unibs.it
OBJECTIVES: This study was designed to evaluate left ventricular (LV) anatomy and function in patients with Cushings syndrome.
BACKGROUND: A high prevalence of LV hypertrophy and concentric remodeling has been reported in Cushings syndrome, although no data have been reported on LV systolic and diastolic function.
METHODS: Forty-two consecutive patients with Cushings syndrome and 42 control subjects, matched for age, gender, and blood pressure, were studied. Left ventricular mass index (LVMI) and relative wall thickness (RWT) were measured by echocardiography, endocardial and midwall fractional shortening (FS) were assessed, and diastolic filling was measured by Doppler transmitral flow.
RESULTS: The RWT was significantly greater in Cushing patients than in controls. Left ventricular hypertrophy and concentric remodeling were observed in 10 and 26 patients with Cushings syndrome, respectively. In Cushing patients, midwall FS was significantly reduced compared with controls (16.2 ± 3% vs. 21 ± 4.5%, p = 0.01). The ratio of transmitral E and A flow velocities was reduced and E deceleration time was prolonged in Cushing patients compared with controls (p = 0.03 and p < 0.001, respectively).
CONCLUSIONS: In patients with Cushings syndrome, cardiac structural changes are associated with reduced midwall systolic performance and with diastolic dysfunction that may contribute to the high risk of cardiovascular events observed in these patients.
|
Abbreviations and Acronyms
| | BP | = blood pressure | | ESS | = end-systolic stress | | FS | = fractional shortening | | LV | = left ventricle/ventricular | | LVMI | = left ventricular mass index | | RWT | = relative wall thickness |
|
This article has been cited by other articles:

|
 |

|
 |
 
D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al.
Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
Circulation,
June 24, 2008;
117(25):
e510 - e526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Christ-Crain, B. Kola, F. Lolli, C. Fekete, D. Seboek, G. Wittmann, D. Feltrin, S. C. Igreja, S. Ajodha, J. Harvey-White, et al.
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome
FASEB J,
June 1, 2008;
22(6):
1672 - 1683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al.
Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research
Hypertension,
June 1, 2008;
51(6):
1403 - 1419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Nemergut, A. S. Dumont, U. T. Barry, and E. R. Laws
Perioperative Management of Patients Undergoing Transsphenoidal Pituitary Surgery
Anesth. Analg.,
October 1, 2005;
101(4):
1170 - 1181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Glorioso, F. Filigheddu, P. P. Parpaglia, A. Soro, C. Troffa, G. Argiolas, and P. Mulatero
11{beta}-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension
Eur. Heart J.,
March 1, 2005;
26(5):
498 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|